Nofima
peptide bioactivity research — pilot lines and clinical peptide trials for diabetes.
- Country
- Norway
Coverage
| CN | EU | US | |
|---|---|---|---|
| aquaculture-seafood | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Marine peptides & nutraceuticals | aquaculture-seafood | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.